Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis
- 1 August 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (8) , 1409-1410
- https://doi.org/10.1128/aac.33.8.1409
Abstract
The in vitro activities of three quinolones (ofloxacin, difloxacin, and ciprofloxacin) were compared with those of trimethoprim-sulfamethoxazole, streptomycin, tetracycline, and rifampin against 47 Brucella melitensis strains. Ofloxacin was the most active of the test antimicrobial agents. It inhibited 90% of B. melitensis strains at a concentration of 0.02 micrograms/ml.This publication has 11 references indexed in Scilit:
- High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytesAntimicrobial Agents and Chemotherapy, 1987
- Pharmacokinetics of ofloxacin after parenteral and oral administrationAntimicrobial Agents and Chemotherapy, 1987
- Difloxacin metabolism and pharmacokinetics in humans after single oral dosesAntimicrobial Agents and Chemotherapy, 1986
- In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensisJournal of Antimicrobial Chemotherapy, 1986
- In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1986
- Comparative Trial of Co-Trimoxazole Versus Tetracycline-Streptomycin in Treating Human BrucellosisThe Journal of Infectious Diseases, 1985
- Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosisAntimicrobial Agents and Chemotherapy, 1985
- In vitro activity of ciprofloxacin againstBrucella melitensisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982